Clinical Trial/Study

The latest data on TAVR, transcatheter mitral valve repair, the use of CT to evaluate chest pain, first report on the use of TAVR embolic protection, denervation for pulmonary arterial hypertension, and outcomes with drug-eluting stents vs. bypass...

Now that transcatheter aortic valve replacement (TAVR) is rapidly becoming an established treatment option, cardiology has shifted focus toward the next major frontier in interventional structural heart technology — transcatheter mitral valve repa...

Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary stent placement were significantly less likely to develop blood clots within their stents or to have a heart attack than those whose treatment fol...

Medtron IN-PACT SFA Trial, drug-eluted balloons

For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral ...

Artificial Heart, Ventricular Assist Device, Heart failure, SynCardia
SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a clinical study of the effectiveness of the SynCardia...
Cardiac Resynchonization Therapy (CRT), Implantable cardioverster defibrillators
Medtronic announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm.
Clinical trial/Study, Heart Valve Repair, CoreValve System
Medtronic revealed new one-year clinical data showing that transcatheter aortic valve replacement (TAVR) with the self-expanding CoreValve System offers...
Thoratec, HeartMate III, VAD, NewYork Presbyterian, trial, ventricular assist
NewYork-Presbyterian Hospital/Columbia University Medical Center is one of a select group of medical centers participating in a clinical trial of a new device...
Covidien DEFINITIVE LE Study Peripheral Artery Disease
The Solitaire Flow Restoration Device from Covidien is among a new generation of devices designed to remove blood clots from blocked brain...
Tilda, Vigila and Celerity leads offer a complete package for physicians to better manage their patients’ individualized needs. Tilda...
The U.S. Food and Drug Administration (FDA) in April 2012 approved an expanded indication for Medtronic’s cardiac resynchronization therapy...

Articles

clinical trial/study, imaging, CT imaging
According to a study published online in the Journal of the American College of Radiology (JACR), large majorities of primary care physicians believe that...
clinical trial/study, stem cell therapies,
The British Heart Foundation (BHF) announced the winners of its annual ‘Reflections of Research’ image competition – reflecting the charity’s research into...
rivaroxaban, Xarelto, safety performance, Janssen, NVAF
A new post-marketing study evaluating the safety of once-daily rivaroxaban (Xarelto) shows, in patients with non-valvular atrial fibrillation (...
ACC 2015 late breaking trials
The latest data on TAVR, transcatheter mitral valve repair, the use of CT to evaluate chest pain, first report on the use of TAVR embolic protection,...

Video Center

The silence is deafening. And since radiology associations, physician groups and vendors have yet...
2 days 2 hours ago
The America College of Cardiology has released its list of key late-breaking clinical trials at the...
1 week 2 days ago
As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict...
4 weeks 3 days ago
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...

Comparison Charts

Sorry there is no data available